Hansen Ree A, Mælandsmo GM, Flatmark K, Russnes HG, Gómez Castañeda M, Aas E. Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study. AO [Internet]. 2022 Aug. 3 [cited 2026 Jul. 17];61(8):955-62. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23741